PFIZER INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
Phase 3
Completed
- Conditions
- Psoriasis
- Interventions
- Device: Enbrel (etanercept)Device: Etanercept
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2012-03-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 421
- Registration Number
- NCT00482170
Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
- First Posted Date
- 2007-05-31
- Last Posted Date
- 2010-08-10
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 102
- Registration Number
- NCT00480636
Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Phase 2
Completed
- Conditions
- Alzheimer Disease
- Interventions
- Biological: QS-21Biological: ACC-001 + QS-21Biological: ACC-001
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2016-01-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 86
- Registration Number
- NCT00479557
- Locations
- 🇩🇪
Unversitätsklinikum Freiburg, Freiburg, Baden- Württemberg, Germany
🇫🇷Hôpital LA GRAVE, TOULOUSE Cedex 9, France
🇪🇸Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction.
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 23
- Registration Number
- NCT00479570
- Locations
- 🇸🇪
Pfizer Investigational Site, Danderyd, Sweden
Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 275
- Registration Number
- NCT00479505
- Locations
- 🇬🇧
Pfizer Investigational Site, Leeds, United Kingdom
Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2009-10-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 94
- Registration Number
- NCT00479492
- Locations
- 🇺🇸
Pfizer Investigational Site, San Antonio, Texas, United States
Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents
Phase 3
Terminated
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Drug: Inhaled insulin (Exubera)Drug: Subcutaneous Insulin (subject's prescribed)
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2018-10-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2
- Registration Number
- NCT00479258
- Locations
- 🇺🇸
Pfizer Investigational Site, Buffalo, New York, United States
Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib
Phase 3
Completed
- Conditions
- Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2013-11-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 512
- Registration Number
- NCT00474786
- Locations
- 🇬🇧
Pfizer Investigational Site, Newcastle upon Tyne, United Kingdom
Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors
- First Posted Date
- 2007-05-17
- Last Posted Date
- 2013-12-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 65
- Registration Number
- NCT00474760
- Locations
- 🇬🇧
Pfizer Investigational Site, Sutton, Surrey, United Kingdom
12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
Phase 2
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: PF-00734200 10 mg QDDrug: PF-00734200 20 mg QDDrug: PF-00734200 5 mg QDDrug: PF-00734200 2 mg QDDrug: Placebo
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2010-06-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 303
- Registration Number
- NCT00473525
- Locations
- 🇸🇪
Pfizer Investigational Site, Stockholm, Sweden
© Copyright 2025. All Rights Reserved by MedPath